• SMC open account icon Open an A/C
    • Open an A/C
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c

Budget News

  • Metropolis Health completes acquisition of Hitech
  • October 23,2021  14:00
  • The acquisition has been funded through internal accruals and debt of Rs 300 crore. Dr. Ganesan, the promoter and founder of Dr Ganesan's Hitech Diagnostic Centre (Hitech), will be part of the leadership team for next few years to enable a smooth transition and integration with Metropolis Healthcare. Metropolis Healthcare will also get access to 31 laboratories including 3 National Accreditation Board for Testing and Calibration Laboratories (NABL) and Indian Council of Medical Research (ICMR) accredited laboratories and 68 collection centres of Hitech. Post completion of the acquisition, Hitech and Centralab has become wholly-owned subsidiary and step down wholly owned subsidiary respectively of the company.

    The acquisition of of Dr Ganesan's Hitech Diagnostic Centre (Hitech) along with its subsidiary Centralab Healthcare Services (Centralab) will help Metropolis Healthcare in - strengthening the leadership position, increase B2C contribution in focus cities, enable deeper penetration in mid-segment of the market and enhance profitability through revenue and cost synergies. On FY21, the revenue of Dr Ganesan's Hitech Diagnostic Centre (Hitech) stood at Rs 124 crore, rising 49% Y-o-Y. The business momentum also continued in FY22 with strong growth across all parameters, the press release highlighted.

    Metropolis Healthcare's consolidated net profit surged to Rs 74.92 crore in Q1 FY22 from Rs 2.88 crore in Q1 FY21. Net sales surged 128.30% year-on-year (Y-o-Y) to Rs 326.76 crore during the quarter.

    Shares of Metropolis Healthcare shed 1.12% to end at Rs 2,826.50 on Friday, 22 October 2021. Metropolis Healthcare is a leading diagnostics company in India with a widespread presence across 19 states in India.

    Powered by Capital Market - Live News

Top News
Economy News

Follow us:

  • fb icon
  • Twitter icon
  • Linkedin
  • you tube

Disclaimer: Investment in securities and commodities market are subject to market risks, read all the related documents carefully before investing. SMC Global Securities Ltd. (CIN : U67120DL1997PLC188881): NSE INB/ INF/INE 230771431, BSE INB/INF 011343937, MSEI INB/INF 260771432, CDSL/NSDL-IN-DP-130-2015, SMC Research Analyst Registration- INH 100001849 I SMC Global Securities Ltd.: NCDEX/MCX (8200)/ NMCE/ICEX-INZ000035839 I SMC Global Securities Ltd.: PMS INP000003435 I SMC Insurance Brokers Pvt. Ltd., IRDAI Regi: No: DB 272/04, License No. 289 Valid from 28-01-2020 to 27-01-2023 I Registered Office: 11/6B, Shanti Chamber, Pusa Road, New Delhi-110005, Tel.: (011) 30111000. For any complaints email –, website:

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time.

The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us.
By submitting your details to SMC, you are authorizing us to send promotional communication through Call/Email/SMS/Whatsapp even though you may be registered under DND.

Insurance is the subject matter of solicitation • All insurance products sold through SMC Insurance Brokers Pvt. Ltd. • Investment Banking Services provided by SMC Capitals Ltd. • Equity PMS and Wealth management services provided by SMC Global Securities Ltd. • IPOs and Mutual Funds distribution services are provided by SMC Global Securities Ltd. • Financing Services provided by Moneywise Financial Services Pvt Ltd. • Commodity broking services provided by SMC Global Securities Ltd. • Real Estate Advisory services are offered through SMC Real Estate Advisors Pvt. Ltd.


Toll-free : 1800-11-0909

Plus Minus 
Copyright ©2016 SMC. All Rights Reserved | Disclaimer | Privacy Policy | RMS Policy | Copyright| Testimonials| Sitemap| Grievance| design agency: triverse| Powered by C-MOTS Infotech (ISO 9001:2015 certified)

Open my trading account now!  X 

* All fields are compulsory